04 Oct, 14:44 - Indian

SENSEX 81735.13 (-0.92)

Nifty 50 25012.4 (-0.94)

Nifty Bank 51499.3 (-0.67)

Nifty IT 41852.35 (0.21)

Nifty Midcap 100 58401.85 (-1.06)

Nifty Next 50 74524.65 (-1.22)

Nifty Pharma 23075.2 (-0.45)

Nifty Smallcap 100 18764.6 (-0.99)

04 Oct, 14:44 - Global

NIKKEI 225 38635.62 (0.22)

HANG SENG 22736.87 (2.82)

S&P 5763.25 (0.03)

Login/Signup

You are Here : Home > Research

31-Jan-2024

Dr Reddys Laboratories

NP up 11.01%

'For the quarter ending Dec 2023, consolidated Net sales (including other operating income) of Dr Reddys Laboratories has increased 6.58% to Rs 7236.8 crore compared to quarter ended Dec 2022.  Sales of Pharmaceutical Services segment has gone up 2.68% to Rs 1,058.00 crore (accounting for 14.12% of total sales).  Sales of Global Generics segment has gone up 6.49% to Rs 6,312.40 crore (accounting for 84.26% of total sales).  Sales of Others segment has gone up 73.08% to Rs 121.50 crore (accounting for 1.62% of total sales).  Inter-segment sales rose Rs 238.40 crore to Rs 255.10 crore.  

Profit before interest, tax and other unallocable items (PBIT) has jumped 5.26% to Rs 4,220.70 crore.  PBIT of Pharmaceutical Services segment rose 63.27% to Rs 230.70 crore (accounting for 5.47% of total PBIT).  PBIT of Global Generics segment rose 2.15% to Rs 3,907.70 crore (accounting for 92.58% of total PBIT). &...



Pleaselogin & subscribe to view the full report.

More Reports
More Reports View Company Information